• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 10, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Temple receives $100,000 from Stop Alzheimer's Now to conduct groundbreaking study

Bioengineer by Bioengineer
January 10, 2019
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Lewis Katz School of Medicine at Temple University


(Philadelphia, PA) – Beneath the amyloid plaques and neurofibrillary tangles that are the hallmark pathological features of Alzheimer’s disease, is another, lesser-known anomaly: the almost complete absence of adult neurogenesis, the process by which new neurons form in the developed brain. Thought to serve a critical role in maintaining memory and learning ability, little is actually known about the significance of reduced adult neurogenesis in Alzheimer’s disease. Now, scientists at the Lewis Katz School of Medicine at Temple University have a chance to find out, thanks to a $100,000 gift from Stop Alzheimer’s Now, a non-profit organization dedicated to eradicating Alzheimer’s disease.

Domenico Praticò, MD, Scott Richards North Star Charitable Foundation Chair for Alzheimer’s Research, Professor in the Departments of Pharmacology and Microbiology and Director of the Alzheimer’s Center at the Katz School of Medicine will be leading the study supported by the Stop Alzheimer’s Now donation.

The new study will test whether inhibition of a specific protein in the brain can stimulate neurogenesis. Dr. Praticò and colleagues previously found that the targeted protein functions as a controller of neurogenesis and demonstrated in vitro that its inhibition triggers the growth of new neurons.

Reinvigorating the endogenous process of adult neurogenesis differs from current trends in the development of stem cell therapies for Alzheimer’s disease, which rely on the administration of stem cells. “The research project is high-risk, high-reward,” Dr. Praticò said. “Our work may not yield a significant result, but if we show that natural adult neurogenesis can be restored, it could lead to big breakthroughs in our understanding of neurogenesis, in addition to the generation of novel therapies for Alzheimer’s disease.”

“The reason I chose Temple [to receive funding] was simple,” said Shaun McDuffee, founder of Stop Alzheimer’s Now. “It was Dr. Praticò and his team. Their dedication, passion, and commitment to wiping out this disease are second to none. I truly believe they will find a cure.”

Stop Alzheimer’s Now (SAN), founded by McDuffee in 2013, has committed to walking across all 50 states to raise awareness and funds for research for a cure. To date, SAN has walked nearly 900 miles and raised over $360,000 through individual contributions and partnerships with organizations such as the Scott Richards North

Star Charitable Foundation and the McDuffee Family Foundation.

“We are very excited and grateful that Stop Alzheimer’s Now has chosen to support our research,” Dr. Praticò added.

###

About Temple Health

Temple University Health System (TUHS) is a $2.1 billion academic health system dedicated to providing access to quality patient care and supporting excellence in medical education and research. The Health System consists of Temple University Hospital (TUH), ranked among the “Best Hospitals” in the region by U.S. News & World Report; TUH-Episcopal Campus; TUH-Northeastern Campus; Fox Chase Cancer Center, an NCI-designated comprehensive cancer center; Jeanes Hospital, a community-based hospital offering medical, surgical and emergency services; Temple Transport Team, a ground and air-ambulance company; and Temple Physicians, Inc., a network of community-based specialty and primary-care physician practices. TUHS is affiliated with the Lewis Katz School of Medicine at Temple University, and Temple University Physicians, which is Temple Health’s physician practice plan comprised of more than 500 full-time and part-time academic physicians in 20 clinical departments.

The Lewis Katz School of Medicine (LKSOM), established in 1901, is one of the nation’s leading medical schools. Each year, the School of Medicine educates more than 800 medical students and approximately 240 graduate students. Based on its level of funding from the National Institutes of Health, the Katz School of Medicine is the second-highest ranked medical school in Philadelphia and the third-highest in the Commonwealth of Pennsylvania. According to U.S. News & World Report, LKSOM is among the top 10 most applied-to medical schools in the nation.

Temple Health refers to the health, education and research activities carried out by the affiliates of Temple University Health System (TUHS) and by the Katz School of Medicine. TUHS neither provides nor controls the provision of health care. All health care is provided by its member organizations or independent health care providers affiliated with TUHS member organizations. Each TUHS member organization is owned and operated pursuant to its governing documents.

Media Contact
Jeremy Walter
[email protected]
267-838-0398

Original Source

https://www.templehealth.org/News/LewisKatzSchoolofMedicineatTempleUniversityReceives100000DonationfromStopAlzheimersNowtoConductGroundbreakingStudy?id=3247&showBack=true&PageIndex=0&cid=13

Tags: AlzheimerMedicine/Healthneurobiology
Share12Tweet8Share2ShareShareShare2

Related Posts

Strong Link Between Dementia Risk and Multiple Co-Existing Mental Health Disorders Revealed

September 10, 2025

Revolutionizing Blood Pumps: Customized Ventricular Assist Device Insights

September 9, 2025

Mayo Clinic Physician Honored with Dr. Scott C. Goodwin Grant for Advancing Adenomyosis Research

September 9, 2025

UCF Develops Free Resiliency Resources to Support Healthcare Workers and Students Globally

September 9, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    51 shares
    Share 20 Tweet 13
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Insatiable Star Devours Its Cosmic Twin at Unprecedented Rate

Breast Cell Changes During Motherhood Offer Insights into Breastfeeding Challenges

Strong Link Between Dementia Risk and Multiple Co-Existing Mental Health Disorders Revealed

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.